ENOV — ENOVIS CORP (Healthcare >> Medical Devices)
ENOV FAQ
What is ENOV's P/E ratio?
ENOVIS CORP (ENOV) currently trades at a P/E ratio of -149.60.
What is ENOV's ROE?
ENOVIS CORP reports a Return on Equity (ROE) of -77.00%.
What is ENOV's dividend yield?
ENOVIS CORP offers a dividend yield of 0.00%.
What is ENOV's Deepscope Quality Score?
Deepscope rates ENOV's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ENOV?
Deepscope's AI Timing Score for ENOV is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ENOV belong to?
ENOVIS CORP is classified under the Healthcare >> Medical Devices sector on the NYSE exchange.
|
USD 22.86
Price
1.30
(6.03%)
Day Change
|
|
|---|
ENOV, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 22.86 |
| PBV / Sector |
0.85 / 7.50
GREAT
|
| Earning Per Share | -20.66 |
| PE / Sector |
N/A / 28.68
|
| PEG or PE/Growth / Sector |
-0.18 / 0.39
|
| Average 1M Daily Value |
25.80 M
GREAT
|
| Average 1W Daily Value |
18.27 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
62% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:12:24 |
| Symbol | ENOV |
| Name | ENOVIS CORP |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 57.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,258.32 / 18,060.39 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2711 Centerville Road, Wilmington, DE, United States, 19808
Phone: 302 252 9160
Website: https://www.enovis.com
Employees: 7,802
Sector: Healthcare >> Medical Devices
Description: Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google